Ulcerative Colitis Symptom Diary: Track Stool Frequency, Blood, Urgency, Pain, and Medication

Most people with ulcerative colitis walk into a gastroenterology appointment and try to summarize three months of bowel habits from memory. The result is usually vague: things have been "okay," or "worse lately." A structured ulcerative colitis symptom diary solves that problem by capturing the exact fields a gastroenterologist uses to score disease activity, so the conversation starts with data instead of recall. The five fields that matter most are stool frequency, blood, urgency, pain, and medication, and each one maps onto a specific piece of a validated activity index.

What your gastroenterologist is actually scoring

The most widely used measure of ulcerative colitis activity is the Mayo score, which combines a stool frequency subscore, a rectal bleeding subscore, an endoscopic subscore, and a physician's global assessment, each rated from 0 to 3 in the ACG clinical guideline on ulcerative colitis in adults. Two of those four components come directly from what you report. Research on the noninvasive components of the Mayo score found that a 6-point score built only from stool frequency and bleeding identified patient-perceived clinical response about as well as the full score, with 88 percent sensitivity at the appropriate cutoff. A diary that records those two fields accurately is doing a large share of the clinical work before you ever sit down. The 2025 ACG guideline update continues to build treatment decisions on this same activity framework.

Stool frequency measured against your own baseline

The Mayo stool frequency subscore is not an absolute count. It asks how many stools you are passing above your own normal: 0 for a normal number, 1 for one to two extra, 2 for three to four extra, and 3 for five or more extra, as set out in the ACG guideline. This is why a diary needs a stated baseline at the top. Someone whose remission baseline is three bowel movements a day and who is now at seven is in different territory from someone whose baseline is one. Nighttime stools deserve their own line. The Simple Clinical Colitis Activity Index scores daytime and nighttime bowel frequency separately, and the ACG guideline specifically instructs clinicians to ask about the number of nocturnal bowel movements when assessing severity.

Blood recorded as a proportion, not just yes or no

Rectal bleeding is the field patients most often flatten into a single yes. The Mayo rectal bleeding subscore is graded by pattern: no blood seen, streaks of blood with stool less than half the time, obvious blood with stool most of the time, or blood passed alone without stool. The ACG guideline directs clinicians to assess bleeding as the proportion of bowel movements mixed with blood, so a diary entry reading "streaks, about 2 of 6 stools" is far more useful than "some blood." Resolution of rectal bleeding is one of the core targets in the STRIDE-II treat-to-target consensus, which names symptomatic relief and normalization of serum and fecal markers as short-term goals and endoscopic healing as a longer-term one. Logging bleeding as a proportion lets your team see whether that target is being met.

Urgency, the field most diaries leave out

Bowel urgency is a distinct symptom from stool frequency, and it is often the one that shapes whether someone can commute, work, or leave the house. The ACG guideline defines symptomatic remission in ulcerative colitis as the absence of both rectal bleeding and urgency, and its proposed activity index grades urgency from none to continuous. There is now a validated way to record it. The Urgency Numeric Rating Scale asks patients to rate the immediacy of their need to have a bowel movement over the past 24 hours on an 11-point scale from 0, meaning no urgency, to 10, meaning worst possible urgency. It was developed under FDA patient-reported outcome guidance and showed high test-retest reliability. Copying that 0 to 10 scale into your diary gives your gastroenterologist a number they already know how to read.

Pain, fatigue, and the fields that signal severity

Abdominal pain, cramping, fatigue, fever, and weight loss round out the picture. NIDDK lists cramping abdominal pain, tenesmus, and passing mucus among common ulcerative colitis symptoms, with fatigue, fever, nausea, and weight loss appearing more often in severe disease. Severity thresholds are worth knowing so you can recognize when a diary entry warrants a phone call rather than a note for the next visit. The ACG guideline describes severe disease as bowel frequency greater than six times a day together with fever, tachycardia, anemia, or an elevated erythrocyte sedimentation rate. A weekly weight, a simple 0 to 10 pain rating, and a note on how many hours of work or sleep were lost give the same information in a form your team can act on.

Medications, doses, and the days you missed

The medication column is the one patients most often skip and clinicians most often need. Ulcerative colitis treatment spans aminosalicylates, corticosteroids, immunosuppressants, biologics, and newer small molecules, and NIDDK notes that most people need medication long term. Record the drug, the dose, the date of each infusion or injection, and any doses you skipped. Missed doses change outcomes: a prospective cohort of patients with quiescent ulcerative colitis found that nonadherence carried a more than fivefold higher risk of recurrence, with a hazard ratio of 5.5. Steroid use is worth flagging separately, since steroid-free remission is the stated goal of therapy in the ACG guideline.

Turning a daily log into an appointment summary

Raw daily entries are hard to interpret in a 15-minute visit, so bring a summary alongside them. A useful format reports the last 7 to 14 days: average daily stools versus baseline, the proportion of stools with blood, average urgency rating, worst pain score, medication doses missed, and any nights with bowel movements. Pair that with objective markers. The AGA guideline on biomarkers in ulcerative colitis recommends a combined biomarker and symptom monitoring strategy over symptoms alone, using fecal calprotectin below 150 micrograms per gram to help rule out active inflammation in people who feel well. A validated patient-reported activity index derived from the Mayo score and SCCAI reached an area under the curve of 0.93 for identifying patient-defined remission using stool frequency, bleeding, and general well-being alone, which is a reasonable summary to aim for.